卷 96, 编号 5 (2024) |
Original articles |
Reduction in the need for glucocorticoids on the background of therapy with biologic disease-modifying antirheumatic drugs and Janus kinase inhibitors in rheumatoid arthritis: evidence from real clinical practice |
(Rus)
|